SCHEMBL8527796

SCHEMBL8527796

O=C1Nc2ccc(S(=O)(=O)O)cc2C1=Cc1ccnc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SYK P43405 6/20 0.51
NTRK1 P04629 5/20 0.51
NTRK3 Q16288 3/20 0.48
NTRK2 Q16620 3/20 0.48
FCER2 P06734 2/20 0.48
PDPK1 O15530 1/20 0.43
CHEK1 O14757 1/20 0.43
RET P07949 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
RPS6KA3 P51812 2/20 0.41
GSK3B P49841 1/20 0.41
FLT3 P36888 1/20 0.40
ALK Q9UM73 1/20 0.40
MAP3K7 O43318 1/20 0.40
TAB1 Q15750 1/20 0.40
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8530208 0.89 SYK (0.64) SYKNTRK1NTRK3NTRK2FCER2
SCHEMBL7137514 0.87 SYK (0.52) SYKNTRK1NTRK3NTRK2FCER2
SCHEMBL8529758 0.84 PDPK1 (0.52) NTRK1PDPK1CHEK1RETTDP1
SCHEMBL8508649 0.82 RPS6KA3 (0.54) SYKNTRK1NTRK3NTRK2FCER2
SCHEMBL7131127 0.82 NTRK1 (0.47) SYKNTRK1NTRK3NTRK2CHEK1
SCHEMBL8301615 0.82 TLK2 (0.58) SYKFCER2PDPK1MEN1KMT2A
SCHEMBL8530158 0.82 RET (0.45) SYKNTRK1PDPK1CHEK1RET
SCHEMBL5728227 0.81 CHEK1 (0.60) NTRK1NTRK3NTRK2CHEK1RET
SCHEMBL5728224 0.81 CHEK1 (0.60) NTRK1NTRK3NTRK2CHEK1RET
SCHEMBL15503691 0.81 CHEK1 (0.60) NTRK1NTRK3NTRK2CHEK1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US claimed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO claimed
US-5840745-A INHIBITING CELL PROLIFERATION, TUMOR GROWTH, METASTASIS, DEVELOPMENT OF ATHEROMATOUS PLAQUE AND RESTENOSIS, CONTROLLING ANGIOGENESIS, TREATING DIABETES, ENHANCING CANCER THERAPY PHARMACIA S. P. A. (IT) 1998-11-24 US disclosed
EP-0752985-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA & UPJOHN S.p.A. (IT) 1997-01-15 EP disclosed
WO-1996022976-A1 HYDROSOLUBLE 3-ARYLIDENE-2-OXINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS PHARMACIA S.P.A. (IT) 1996-08-01 WO disclosed